Market revenue in 2022 | USD 88.9 million |
Market revenue in 2030 | USD 137.6 million |
Growth rate | 5.6% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data | 2016 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , U.S. , UK , Japan , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.39% in 2022. Horizon Databook has segmented the India orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
As per article published in Business Standard in April 2019, RegenOrthoSport, the country’s Regenexx center that offers advanced stem cell and blood platelet procedures, accomplished 481 regenerative procedures in 2.5 years. In July 2017, a RegenOrthoSport facility was inaugurated in Mumbai. Thus, such growing number of facilities are expected to allow improved product penetration during the forecast period.
Furthermore, as per the Ministry of Health and Family Welfare, Government of India, the prevalence of osteoarthritis is between 22% and 39% in the country, and this is estimated to increase over time. Such factors are expected to offer opportunities to market players to cater to the growing the demand.
Horizon Databook provides a detailed overview of country-level data and insights on the India orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into India orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account